10 45

INTEGRATING PRIVATE- AND PUBLIC-SECTOR SURVEILLANCE: WHAT IS HAPPENING AND WHAT IS NEEDED

Rosamund Williams, WHO

Renu Gupta, Bristol-Myers Squibb

Laurence McCarthy, MRL Pharmaceutical Services

11:30

SURVEILLANCE AND THE LABORATORY: WHAT ARE THE ISSUES?

Fred Tenover, CDC

11:45

HOW CAN THE SCIENCE HELP?

Implications of Mapping the Genome

Craig Venter, Institute for Genomic Research

 

Molecular Detection of Genes Associated with Antimicrobial Resistance

David Relman, Stanford University

12:30

LUNCH

1:30

HOW CAN THE SCIENCE HELP? (continued)

High-Density Oligonucleotide Arrays

Tom Gingeras, Affymetrix

 

Applications of Genomics/Bioinformatics to Development of Anti-Infectives

George Miller, Schering-Plough Research Institute

 

A Role for New Therapeutic Approaches in Combating Antimicrobial Resistance

Mich Hein, EPIcyte

 

Applications of Field Surveillance (U.S. and International)

Thomas Quinn, Johns Hopkins University

2:30

SOURCES OF RESISTANCE AND NOTIONS OF RESPONSE

Stuart Levy, Tufts University

2:45

ISSUES OF JUDICIOUS ANTIBIOTIC USE

Mitchell Cohen, CDC

3:00

ISSUES IN AND STRATEGIES FOR CLINICAL USE OF ANTIMICROBIALS

Michael Marcy, Kaiser Permanente



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement